| RS2546165318 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Late-infantile neuronal ceroid lipofuscinosis |
| RS2546166179 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546166888 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546167400 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546167853 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2546169588 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 8, Bardet-Biedl syndrome 8 |
| RS2546170566 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546170602 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546171803 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS2546175066 |
TTC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 51, Bardet-Biedl syndrome |
| RS2546180341 |
OBSL1
|
Health Risk |
Likely pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS2546193322 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546193716 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546193734 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546193773 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546194616 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2546203255 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546211394 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS2546211584 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS2546212098 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS2546212330 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2546212520 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546212753 |
TTC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 8 |
| RS2546217470 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2546230995 |
TTC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Retinitis pigmentosa 51 |
| RS2546231494 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2546233249 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, 3M syndrome 2 |
| RS2546234808 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546234815 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546236188 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546237065 |
TTC8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2546237444 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546240502 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546240643 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546241222 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546246459 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546247192 |
PTPN23
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity |
| RS2546247239 |
OBSL1
|
Health Risk |
Likely pathogenic |
OBSL1-related disorder, OBSL1-related disorder |
| RS2546247318 |
PTPN23
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, PTPN23-related disorder |
| RS2546247822 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546248424 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546249090 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS2546249724 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546251685 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546251911 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546252750 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546254135 |
SLC2A9
|
Health Risk |
Pathogenic |
— |
| RS2546256203 |
PTPN23
|
Health Risk |
Pathogenic |
— |
| RS2546256341 |
PTPN23
|
Health Risk |
Likely pathogenic |
— |
| RS2546258996 |
PTPN23
|
Health Risk |
Likely pathogenic |
— |
| RS2546268710 |
TRIM37
|
Health Risk |
Likely pathogenic |
— |
| RS2546271493 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546280571 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS2546295090 |
OBSL1
|
Health Risk |
Likely pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS2546334707 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546335307 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335395 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335527 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335552 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335558 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335679 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335696 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335698 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335765 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546335768 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335813 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335891 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335895 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335940 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546335980 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546337476 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546337480 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546337484 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546337523 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546337573 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546339446 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546339447 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546339507 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546339598 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546339600 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546340450 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS2546340528 |
SIL1
|
Health Risk |
Pathogenic |
— |
| RS2546342886 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546342956 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546342963 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344787 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344807 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344826 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344966 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344970 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546344998 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345169 |
SIL1
|
Health Risk |
Likely pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS2546345800 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345815 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345912 |
MMAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345935 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345956 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546345991 |
MMAA
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblA type |
| RS2546354841 |
ROBO1
|
Health Risk |
Likely pathogenic |
ROBO1-related disorder, ROBO1-related disorder |
| RS2546366412 |
SIL1
|
Health Risk |
Likely pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |